MedTrace Logo

Lornoxicam Versus Etodolac After Third Molar Surgery

NCT05679453 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-01-11

No results posted yet for this study

Summary

Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction

Conditions

  • Pain, Acute
  • Edema
  • Trismus

Interventions

DRUG

Lornoxicam 8 Mg Oral Tablet

Lornoxicam is a oxicam grup non-steroid antiinflamatuar drug

Sponsors & Collaborators

  • Kutahya Health Sciences University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-20
Primary Completion
2022-09-25
Completion
2022-09-29

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05679453 on ClinicalTrials.gov